Involvement of environmentally relevant toxic metal mixture in Alzheimer's disease pathway alteration and protective role of berberine: Bioinformatics analysis and toxicogenomic screening

Živančević, Katarina; Baralić, Katarina; Božić, Dragica; Miljaković, Evica Antonijević; Djordjević, Aleksandra Buha; Ćurčić, Marijana; Bulat, Zorica; Antonijević, Biljana; Bulat, Petar; Đukić-Ćosić, Danijela

doi:10.1016/j.fct.2022.112839

Cited by 17 publications

(5 citation statements)

References 99 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 71 It down-regulates NF-κB and activates iκB, IL-1β and TNF-α by blocking PI3K-Akt and MAPK signaling pathways, 72 and regulating apoptosis and oxidative stress. 73 Therefore, berberine can alleviate cognitive impairment, and this potential therapeutic mechanism is related to inhibiting p-tau hyperphosphorylation and NF-κB signal. 74 Yan found that bitter cardamom has an anti-inflammatory effect and can reduce the damage of lipopolysaccharide for nerve cells through PI3K-Akt/NF-κB pathway, 75 and improve the learning and memory of model mice.…”

Section: Discussionmentioning

confidence: 99%

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway

Zhang

Wang

Zhu

et al. 2023

NDT

View full text Add to dashboard Cite

Objective The objective of this study was to explore the neuroprotective mechanism of JDYZF in treating AD from the perspective of inflammation and intestinal microflora. Methods A total of 24 APP/PS1 mice were randomly divided into four groups: model (n = 6), JDYZF low-dose (n = 6), JDYZF high-dose (n = 6), and positive drug (n = 6), six C57 mice were used as the control group. The body weights and diets of all mice were examined daily. After 8 weeks of administration, the learning and memory of mice were evaluated by the Morris water maze test. The histopathological changes of hippocampus, liver and kidney in mice were observed by HE staining after being euthanized. The expression of p-tau in hippocampus tissue was detected by immunohistochemistry. After that, 16S rDNA sequencing was used to investigate the relationship between JDYZF and intestinal microbiota. Finally, a comparison of TLR4, p65, p-p65, iκB, p-iκB, and IL-1β protein expression in the hippocampus tissue of mice in each group was measured by Western blot. Results The results showed that APP/PS1 mice taking JDYZF orally were generally in good condition. Compared with the control group, JDYZF significantly improved learning and memory ability in ethology. Histology showed that JDYZF improved the hippocampal structure of mice and inhibited the deposition of p-tau. JDYZF treatment could regulate the gut microbiota of APP/PS1 mice by increasing the richness of Lachnospiraceae, Ruminococcaceae , and Actinobacteria and reducing that of Alistipes and Muribaculaceae . It also significantly inhibited the activation of the TLR4/NF-κB signaling pathway in the brain. In addition, no obvious toxic reactions were found in the liver and kidney of APP/PS1 mice after taking JDYZF for 8 weeks. Conclusion The findings revealed that JDYZF improved cognitive ability and alleviated the TLR4/NF-κB signaling pathway in APP/PS1 mice, and the modulating the gut microbiota presented here may help illuminate its activation mechanism.

show abstract

Section: Discussionmentioning

confidence: 99%

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway

Zhang

Wang

Zhu

et al. 2023

NDT

View full text Add to dashboard Cite

show abstract

“…Berberine is a protoberberine alkaloid with an isoquinoline structure that can be extracted from traditional Chinese medicines such as Coptis Rhizoma, Cortex Phellodendri, and Sangean. Pharmacological studies suggest that berberine has a variety of pharmacological effects, such as regulation of blood sugar and blood lipids and anti-inflammatory and antiviral effects ( Živančević et al, 2022 ). In addition, berberine can not only improve the spatial learning and memory of AD model rats but also inhibit the aggregation of Aβ and tau hyperphosphorylation and is one of the potential drugs for the prevention and treatment of AD ( Fang et al, 2020 ; Raju et al, 2021 ).…”

Section: Nanoparticle-loaded Natural Medicines For Admentioning

confidence: 99%

Nanoparticles loaded with natural medicines for the treatment of Alzheimer’s disease

Liu,

Ruan,

et al. 2023

Front. Neurosci.

View full text Add to dashboard Cite

Alzheimer’s disease (AD) is a progressive neurodegenerative disease that disrupts cognitive function and severely affects the quality of life. Existing drugs only improve cognitive function and provide temporary relief of symptoms but do not stop or delay disease progression. Recently, natural medicines, especially Chinese herbal medicines, have gained attention in the treatment of AD due to their antioxidant, anti-inflammatory, and neuroprotective effects. However, conventional oral dosage forms lack brain specificity and have side effects that lead to poor patient compliance. Utilizing nanomedicine is a promising approach to improve brain specificity, bioavailability, and patient compliance. This review evaluates recent advances in the treatment of AD with nanoparticles containing various natural medicines. This review highlights that nanoparticles containing natural medicines are a promising strategy for the treatment of AD. It is believed that this technology can be translated into the clinic, thereby providing opportunities for AD patients to participate in social activities.

show abstract

“…It has been used in Traditional Chinese Medical systems in China and Ayurvedic system in India for a very long time ( Gaba et al, 2021 ; Xu et al, 2021 ). Modern pharmacological studies have proved that BBR has abundant biological activities including anti-inflammatory ( Bai et al, 2020 ; Ma et al, 2020 ; Fu et al, 2021 ), anti-oxidant ( Eissa et al, 2018 ; Seth et al, 2021 ), anti-bacterial ( Wang et al, 2009 ; Avci et al, 2018 ; Tong et al, 2021 ), viricide ( Hayashi et al, 2007 ; Cecil et al, 2011 ; Hung et al, 2019 ), cardiovascular protection ( Salehi and Filtz, 2011 ; Li et al, 2014 ; Wang L. et al, 2020 ), hypolipidemic ( Hu et al, 2012 ; Zhou et al, 2014 ), anti-diabetic ( Lee et al, 2006 ; Ye et al, 2016 ; Di et al, 2021 ), anti-tumor ( Liu et al, 2017 ; Zhang et al, 2020 ; Ren et al, 2021 ), anti-ulcer ( Li et al, 2020 ; Xiong et al, 2021 ), anti-neurodegeneration ( Liang et al, 2017 ; Hussien et al, 2018 ; Živančević et al, 2022 ), and anti-rheumatoid arthritis ( Huang et al, 2021 ; Li et al, 2022 ) ( Figure 1 ).…”

Section: Introductionmentioning

confidence: 99%

Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review

Mou

Deng

et al. 2022

Front. Pharmacol.

View full text Add to dashboard Cite

Berberine (BBR) is a plant derived quaternary benzylisoquinoline alkaloid, which has been widely used in traditional medicines for a long term. It possesses broad pharmacological effects and is widely applied in clinical. In recent years, the anti-tumor effects of BBR have attracted more and more attention of the researchers. The canonical right-handed double-stranded helical deoxyribonucleic acid (B-DNA) and its polymorphs occur under various environmental conditions and are involved in a plethora of genetic instability-related diseases especially tumor. BBR showed differential binding effects towards various polymorphic DNA structures. But its poor lipophilicity and fast metabolism limited its clinical utility. Structural modification of BBR is an effective approach to improve its DNA binding activity and bioavailability in vivo. A large number of studies dedicated to improving the binding affinities of BBR towards different DNA structures have been carried out and achieved tremendous advancements. In this article, the main achievements of BBR derivatives in polymorphic DNA structures binding researches in recent 20 years were reviewed. The structural modification strategy of BBR, the DNA binding effects of its derivatives, and the structure activity relationship (SAR) analysis have also been discussed.

show abstract

Involvement of environmentally relevant toxic metal mixture in Alzheimer's disease pathway alteration and protective role of berberine: Bioinformatics analysis and toxicogenomic screening

Cited by 17 publications

References 99 publications

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway

Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway

Nanoparticles loaded with natural medicines for the treatment of Alzheimer’s disease

Structural modifications of berberine and their binding effects towards polymorphic deoxyribonucleic acid structures: A review

Contact Info

Product

Resources

About